Skip to main content

Market Overview

8 Stocks Moving In Monday's After-Hours Session

Share:

Gainers

  • Enzo Biochem (NYSE: ENZ) shares are trading higher after the company reported Q2 EPS and sales results were higher year over year.
  • ISun (NASDAQ: ISUN) shares are trading higher after the company reported Q4 EPS and sales results were higher year over year.
  • Zedge (AMEX:ZDGE) shares are trading higher after the company reported better-than-expected Q2 EPS and sales results. The company reported it sees FY21 sales growth of 75-80%.
  • Fulgent Genetics (NASDAQ: FLGT) shares are trading higher after the company announced it was awarded a contract from the CDC to study variants of the COVID-19 virus.

Losers

  • Option Care Health (NASDAQ: OPCH) shares are trading lower after the company reported a 12 million share common stock offering via selling shareholders.
  • Cleanspark (NASDAQ: CLSK) shares are trading lower after the company announced the launch of an underwritten public offering. No terms were disclosed.
  • Solid Biosciences (NASDAQ: SLDB) shares are trading lower after the company reported efficacy and safety data from the ongoing IGNITE DMD clinical trial.
  • Nikola (NASDAQ: NKLA) shares are trading lower after the company's S-1 filing showed registration for a $100 million common stock offering.
 

Related Articles (ENZ + CLSK)

View Comments and Join the Discussion!

Posted-In: News Penny Stocks Small Cap After-Hours Center Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com